Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3585_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
102 Мб
Скачать
ab ab
1.9 Troubleshooting
Fig. 1.219 Coronary artery perforation by a
guidewire. (a) To control hemorrhage from a side branch, place a balloon in the main vessel across the branching point, and inate it at a low pressure. (b) To control hemorrhage from the main vessel, place a balloon in the vessel at the site of hemorrhage, and inate it at a low pressure
149
a
b
Fig. 1.220 Hemorrhage from
the distal coronary artery segment (a). Place a balloon in the proximal segment, and inate it at a low pressure. Conrm that the distal segment is not visualized during balloon ination (b)
Fig. 1.221 Hemorrhage after
stenting a CTO of the LCX (a). Hemostasis was achieved by inating a balloon in the lesion at a low pressure (b)
150
ab
ab
1 Mitsudo’s PCI Techniques forCTO
1.9.3 Perforation or Laceration ofaRetrograde Collateral Channel
Perforation or laceration of a septal channel is not so seri­ous. Even if it leads to intramyocardial bleeding, blood will ow into the ventricle and rarely creates a large hematoma in the myocardium. However, if there is a hematoma show­ing progressive enlargement and poor clearance of contrast medium, you should take measures to secure hemostasis. If bleeding into the ventricle does not occur, the perforation
Fig. 1.222 Septal channel
perforation caused by inating a balloon after a microcatheter failed to cross the channel (a). The hematoma was enlarging and showed poor washout of contrast medium, so a coil was implanted to achieve hemostasis (b)
is probably large, so a coil is more reliable for stopping the bleeding than a blood clot or a block of subcutaneous fat (Fig.1.222). After successful hemostasis, similar measures should be taken from the contralateral side (Fig.1.223).
If there is intramyocardial bleeding, it is difcult to esti­mate the size of the connection between the artery and the cardiac chamber. In this case, coil embolization should basi­cally not be performed (Fig.1.224) because the connection may be too large to retain a coil that is delivered as a hemo­static plug.
Fig. 1.223 Septal channel
perforation caused by ination of a balloon after a microcatheter failed to cross the channel retrogradely from the LAD in a patient with CTO of the RCA.The hematoma was enlarging and showed poor washout of contrast medium, so a coil was implanted from the LAD.Angiography of the RCA showed bleeding (a), so a coil was also implanted from the RCA to consolidate hemostasis (b)
1.9 Troubleshooting
a b c
151
Fig. 1.224 Connection to the right ventricle created by a guidewire
during retrograde tracking of a septal channel from the LAD in a patient with CTO of the RCA (a & b). The patient was followed up without any
1.9.4 Uncontrollable Bleeding: Management ofCoronary Perforation
Typical cases are presented below (Figs.1.225 & 1.226).
specic treatment. After 3months, CAG conrmed disappearance of the connection to the ventricle (c)
152
bc
1 Mitsudo’s PCI Techniques forCTO
a
Retrograde
ConPro12
Antegrade ConPro30
POBA
1.25 mm
Retrograde wire
not cross
Antegrade
Runthrough
hypercoat
POBA
1.25 mm
Retrograde
ConPro12
d
ef g
h
Covered stent
3.0×16mm16 atm
POBA 3.0mm
POBA 2.5mm
1.9 Troubleshooting
153
Fig. 1.225 Bleeding during PCI for CTO of the RCA (1) (a). (b) The
retrograde guidewire was parallel with the antegrade guidewire in the proximal true lumen and followed the same route when manipulated repeatedly. It reached a site of resistance, and the tip was deected when the guidewire was pushed further, indicating that the tip was in the subintimal space. Since reverse CART could not be accomplished, CART was attempted, and antegrade crossing of the CTO was success­ful. Subsequent CAG showed coronary artery perforation (c), and IVUS conrmed that the antegrade guidewire was outside the vessel wall (d).
a
b c
Antegrade
Gaia First
After the antegrade guidewire was anchored with a retrograde balloon, a covered stent was delivered and implanted (e). To control persistent hemorrhage (f), another covered stent was implanted, and prolonged plain old balloon angioplasty (POBA) was performed from both direc­tions. Simultaneously, protamine was injected intravenously (g). Hemostasis was achieved and the CTO was successfully recanalized (h)
Retrograde
Gaia Third
de f
Fig. 1.226 Bleeding during PCI for CTO of the RCA (2) (a). (Images
generously provided by Dr. Ryohei Yoshikawa, Sanda City Hospital) After reverse CART appeared to be successful (b), externalization was done, and the lesion was dilated with a 2.00-mm balloon. However, IVUS showed that the guidewire ran outside the vessel wall in the seg­ment where subintimal tracking occurred (c). CAG revealed coronary artery perforation (arrow) (d). A GuideLiner catheter was advanced,
and a covered stent was delivered through the catheter at the site of bleeding (e). The GuideLiner catheter not only facilitates smooth deliv­ery of a difcult stent (e.g., a covered stent) but also has a physical hemostatic effect and helps identify the site of bleeding by tip injection. In this case, hemostasis was achieved by placing a covered stent at the bleeding point. Then PCI was completed successfully by implanting DES at the proximal and distal stenotic lesions (f)
Stenting ofBifurcation Lesions
2
With regard to stenting of bifurcation lesions, the choice between one and two stents, the need for kissing balloon ina­tion (KBI) following implantation of a single stent, and the optimal two-stent technique have been controversial issues. Some recent studies have provided evidence that the proximal optimization technique (POT) is useful for bifurcation stent­ing, while other reports have suggested the importance of understanding the relationship between the diameters of the two distal vessels and that of the proximal vessel when per­forming PCI for bifurcation lesions. Various dedicated bifur­cation stents and balloons have been developed. The usefulness of bioresorbable vascular scaffold (BVS) systems when per­forming PCI for bifurcation lesions has also been suggested.
This chapter reviews several stenting strategies and tech­niques that can be used for bifurcation lesions. Although there is no evidence to support the superiority of these strate­gies/techniques over others, there also seem to be no data to justify the solutions to the previous controversies.
For example, the controversy over the choice between one and two stents appears to have been resolved with the con­clusion that a single stent is better, but is this really correct? The angiographic and clinical outcomes after bifurcation stenting using general-purpose stents may be inuenced by several factors, including (1) the stent design, (2) the stenting technique (provisional T-stenting, culotte stenting, crush stenting, etc.), (3) the details of stent implantation (point of
stent wire crossing, use of the Crusade, timing of proximal optimization, kissing balloon ination [KBI], etc.), (4) the extent of jailing or stent malapposition, and (5) unfavorable stent deformation.
Some stents are not designed for bifurcation stenting, while others are only compatible with certain stenting tech­niques. If a stent with an unsuitable design is selected, it may be impossible to prevent jailing or malapposition when it is used for a bifurcation lesion. KBI may not sufciently expand the proximal part of some stents. The stenting tech­nique has an inuence on the risk of jailing, stent malapposi­tion, and stent deformation. The outcome of single versus double stenting of bifurcation lesions should be compared after optimization of all these factors, but it is doubtful that previous studies comparing one versus two stents achieved optimization of other factors. If any of these factors is under­going clinical evolution, at least the best-available current combination of stenting techniques and stent implantation methods should be employed when comparing single and double stenting. However, none of the previous studies com­paring one or two stents employed a standardized (opti­mized) stenting protocol with regard to stent design and the details of stent implantation.
This chapter describes the evolving state-of-the-art proce­dures for bifurcation stenting using general-purpose stents and reviews the rationale for current practice.
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2021 K. Mitsudo, Non-Pushing PCI Techniques, https://doi.org/10.1007/978-981-15-7043-8_2
155
156
Column 12 Stent Design and Stenting Technique
2 Stenting ofBifurcation Lesions
The design of a stent often limits the choices of stenting techniques and the details of stent implantation. That is, stents with a certain design can only be implanted by using certain techniques in certain situations.
Some interventionalists formerly used a Cypher stent to treat left main trunk (LMT) bifurcation lesions. The aver­age diameter of the LAD ostium is 3.5mm, and it may sometimes be larger than 4mm. After expansion by KBI, the strut cells of the Cypher stent open up to <3.5mm (Fig.2.1a). Although balloon ination in the side branch (SB) appears to cause wider opening of the strut cells on imaging (which is two- dimensional), KBI has to produce three­dimensional stent expansion, leading to insufcient strut cell opening for access to the SB when the reference diameter is 3.5mm at the ostium. This inevitably results in jailing and stent malapposition. When culotte stenting is performed by placing a stent from the LMT to the LCX after stenting from the LMT to the LAD, the main branch (LAD) ostium is jailed instead of the SB (LCX) ostium (Fig.2.1b). A stenting technique that results in jailing of the main branch (MB) is absolutely undesirable. Performing treatment on the basis that you do not know what is possible until you try it is not good science or medicine.
In order to perform culotte stenting of an LMT bifurcation lesion, we need stents that are designed to prevent jailing of the LAD after LCX stenting and KBI.If such stents are not available, research should focus on developing something suit­able. In fact, an appropriate stent has already been developed in Japan (Fig.2.2). This stent can be expanded up to 6mm and has made a signicant contribution to stenting of LMT bifurcation lesions, as well as other lesions in large coronary arteries.
If protecting the SB is not considered important along with the risk of SB jailing or plaque shift, it may be felt that crossover stenting (placing a stent in the MB across the SB) with or without POT is sufcient. If a Cypher stent (6-link BX Velocity stent) is used for bifurcation stenting, it would be better to omit KBI, because this stent is likely to show suboptimal expansion with jailing of the SB and because KBI leads to unnecessary stress on the SB.In contrast, using a 2-link stent that permits optimal dilatation of both MB and SB will probably result in a satisfactory outcome after KBI.If it is combined with an optimal stenting technique and optimal stent implantation, a 2-link stent can make a two-stent strategy practicable. If stenting techniques are adopted on the basis of minimizing the risk of jailing (dis­cussed later), culotte stenting will often be superior to crossover stenting.
When SB rewiring is done after stent implantation in the MB, I have proposed that the wire should cross the strut through the most distal cell at the SB ostium since around the time when the Wiktor stent was introduced. This proposal is based on the assumption that bifurcation stenting will always be performed by using coil or ring stents with 0 to 2 links (Wiktor, AVE Microstent, GFX, S-6, S-7, Endeavor [Driver], and Nobori [S-Stent]), and not with stents that have a larger number of links.
Fig. 2.1 A BX Velocity stent (Cypher stent platform)
after expansion by ination of two 3.0-mm kissing
balloons. (a) The stent in the SB has not expanded to
3.0mm, with an indentation at the carina. Ination of two
3.5-mm kissing balloons also failed to sufciently expand
a 3.5- mm stent in the SB, which had the same design as
the 3.0-mm stent. (b) Culotte stenting with these stents
leads to jailing of the MB (arrow)
a
b
Side branch (SB)
Main branch (MB)
2 Stenting ofBifurcation Lesions
157
Fig. 2.2 Nobori stent. (a) A 3.5-mm
Nobori stent expanded with two 3.5-mm kissing balloons inated at their nominal pressure. (b) A Nobori stent expanded to an estimated proximal diameter of 5.8mm with two 4.0-mm kissing balloons, leaving no indentations
a
b
Next, I will discuss the implications of the MB stent wire crossing through the most distal cell of a Cypher stent at the SB ostium. Figure2.3a, b shows diagrams of the structure of 2-link Driver and 6-link BX Velocity stents on the same scale. The blue circles have a diameter of 3.5mm. In the case of the Cypher stent, a wire crossing through the most distal cell as indicated by one red dot within the circle would cause minimal SB jailing, whereas a wire crossing through the most distal cell as indicated by the other red dot within the circle would aggravate SB jailing. There is no other route for the wire that minimizes the risk of SB jailing. With the Driver stent, if the wire crosses through the cell as indicated by either red dot, it will only cause minimal SB jailing, even if jailing cannot be completely avoided. Figure2.4a–e shows structural diagrams of currently available stents on almost the same scale. By moving the blue circle over the view of each stent, it is possible to estimate the extent of SB jailing when the wire crosses through dif­ferent cells.
The crush stenting technique (Fig.2.5a) was developed with introduction of the Cypher stent. Regarding this tech­nique, many interventionalists have suggested the risk of the wire crossing a non-apposed stent through a cell distal to the carina. In addition, crush stenting leads to three layers of struts overlapping in part of the proximal MB and limits subsequent strategies if treatment of restenosis is required. Also, this technique has never been used with BMS.Due to its closed cell design, the Cypher stent is crushed parallel to the MB wall. On the other hand, a 2-link stent is crushed in an oblique direction to the MB wall, which may prevent introduction of a guidewire into the SB across the stent. Moreover, overlapping of three strut layers impairs conformability of the stent. At best, the crush stenting technique is only useful for placing Cypher stents at bifurcation lesions.
What about the V-stenting (simultaneous kissing stenting [SKS]) technique (Fig.2.5b)? Considering its principle, SKS will cause stent malapposition and is far from the ideal method for bifurcation stenting (mentioned later). This technique is also only practicable with multi-link stents that have a closed cell design. When it is used with stents that have no links or a few links, the overlapping stent struts will interlock with each other, and this will gradually reduce the diameters of stents expanded simultaneously.
The strategy for bifurcation stenting can only be optimized when a stenting technique is chosen that is compatible with the stent design and when stent implantation is as sophisticated as possible. The feasibility of adopting a particular stenting strategy also depends on lesion anatomy. Therefore, we should not compare the outcomes achieved with one versus two stents or classify individual techniques as good or bad strategies without considering the various technical aspects of bifurcation stenting.
Comprehensive evidence can only be obtained by comparison of all possible combinations of stent design and stent­ing techniques, but performing such comparisons is not practical. Therefore, we need to devise optimal stenting strate­gies on the basis of theoretical principles, as well as the results of bench tests and stent expansion experiments using models.
158
ab
a
d
bc
a
Fig. 2.3 Structural
diagrams of 2-link and 6-link stents. (a) Driver stent. (b) Cypher (BX Velocity) stent
2 Stenting ofBifurcation Lesions
1
2
9
4
5
3
6
14
7
12
10
8
13
11
21
26
19
17
15
16
24
22
20
25
18
23
e
Fig. 2.4 Structural diagrams of currently available stents. (a) Resolute Integrity stent. (b) Xience Prime stent. (c) PROMUS
Element stent. (d) Nobori stent. (e) Ultimaster stent
Fig. 2.5 Stenting techniques. (a)
Crush stenting. (b) V-stenting or
simultaneous kissing stenting (SKS)
b
2.1 Dedicated Bifurcation Stents
Various dedicated bifurcation stents have been developed and can be classied into several categories. Many of them can be used to achieve satisfactory outcomes if the stent is positioned optimally so that its carina ts into the SB
ostium. However, it is often challenging, and sometimes nearly impossible, to achieve optimal positioning of a ded­icated bifurcation stent (Fig.2.6). The greatest limitation of dedicated bifurcation stents is probably the xed dis­tance between the proximal edge and carina. The stent may be too short for full coverage of the proximal MB
2.1 Dedicated Bifurcation Stents
159
including its ostium, which will then require implantation of an additional stent for this purpose. Alternatively, the stent may be too long to allow the proximal edge to remain within the MB lumen, precluding its use.
Various difculties may be encountered during bifurcation
stenting with a dedicated stent. If a stent mounted on two bal­loons becomes blocked by an obstacle in the lumen during delivery, it is often difcult to withdraw the stent into the guid­ing catheter and reattempt advancement. This is because mount­ing the stent on two balloons makes it very bulky and liable to become stuck, deformed, or lost during withdrawal into the guiding catheter. Another signicant limitation of a dedicated bifurcation stent is that repositioning the stent to improve access to the SB may be impossible after initial failure to place it in the optimal position (Fig.2.7). SB rewiring through a strut cell far from the carina may be required, resulting in loss of the original advantage of the dedicated stent (Fig.2.8).
Thus, the dedicated bifurcation stents developed so far
have various limitations, including little exibility of indica­tions, complexity of the stenting procedure, and difculty in correcting the stent position/direction. These limitations have prevented their extensive use in PCI.
Next, I will consider the designs of several of the dedicated
bifurcation stents that are currently available. Many dedicated stents have been developed, all of which have embodied inter­esting concepts. However, further assessment is needed to determine whether any of these dedicated stents is sufciently useful for performing optimal bifurcation stenting.
Figure 2.9 shows the dedicated bifurcation stent developed
by Advanced Stent Technologies. Although this stent has an extendable petal that is a very interesting idea, the design raises important questions such as whether its carina can always reach the vascular carina between the MB and the SB and whether the center of the petal can be positioned precisely at the center of the SB lumen (Fig.2.7). In addition, this stent may show poor conformability with the SB at its origin.
Figure 2.10 displays Abbott’s dedicated bifurcation stent.
It has a simple design and is intended for simultaneous stent implantation and KBI.This attractive stent mimics a general­purpose stent suitable for provisional stenting that has been applied to a bifurcation lesion. However, it also has limita­tions, including difculty in achieving optimal positioning and proper alignment of the carina (i.e., the distance from the vessel carina and orientation relative to the SB). Also, the position of this stent cannot be corrected. If the stent is posi­tioned wrongly, SB rewiring has to be performed through a different strut cell, followed by KBI, resulting in loss of the original functionality of a dedicated stent (Fig.2.8).
Figure 2.11 illustrates the dedicated stent system devel-
oped by Advanced Bifurcation Systems. This system is designed to deliver a stent to the SB rst so as to automati­cally achieve optimal alignment. Although it is interesting, this stent does not appear to conserve dynamic conformabil­ity with the SB origin and thus may not ensure optimal align­ment if guidewire entanglement occurs.
Figure 2.12 illustrates the Y stent developed by Medtronic, which joins two Driver stents into a “Y” shape. If it can be implanted at a bifurcation lesion without defor­mation, its design appears to ensure optimal bifurcation stenting. However, optimizing the carinal position and align­ment remain challenging with this stent, while inability to correct suboptimal carinal position and alignment is another limitation.
The Tryton stent is displayed in Fig.2.13. This stent is based on a unique concept and may be practical, with the stent being composed of three zones (Fig.2.13a). The distal zone (SB zone) is implanted in the SB, while the proximal zone for the MB (MB zone) consists of a wedding band and a triple linkage to the middle zone, which is referred to as the transit zone. Two types of stent delivery balloon are available, a stepped balloon and a straight balloon. The Tryton stent can be implanted by a “simplied” culotte stenting technique, which involves implanting the SB stent, inserting the SB guidewire into the MB, implanting the MB stent, reinserting the guidewire into the SB, and nal KBI (Fig. 2.13b). However, it cannot be used for provisional stenting. Also, the transit zone has very little radial strength, so it may not be able to provide an adequate scaffold at the carina.
The STENTYS stent is shown in Fig.2.14. It has a unique self-expanding mesh linked by small interconnections between the struts, which can be disconnected by KBI.This structure will ensure almost optimal bifurcation stenting plus KBI if the SB take-off angle from the proximal MB is medium to small. If the SB take-off angle is large, conform­ability of this stent is insufcient to ensure excellent apposi­tion in the SB and possibly in the MB on the contralateral side. Also, its self-expanding nature prevents correction of malapposition by KBI.
The AXXESS stent is displayed in Fig.2.15. It is a self- expanding stent designed to treat bifurcation lesions of the LMT or other large coronary arteries. Although they can­not be seen in this gure, the stent has one and three mark­ers at the proximal and distal edges, respectively, for optimizing its position. As its distal end expands into an elliptical bell, the strut edge becomes orthogonal to the longitudinal axis of each branch. This results in little or no overlap between it and the stent implanted in one branch and also minimizes jailing of the other branch. The bell at the distal end of the stent can expand to a diameter as large as 8–12mm. This allows conformity to a bifurcation with a large SB take-off angle, but possibly not to a distal LMT bifurcation with a large SB take-off angle versus the LMT.In addition, if the proximal LMT has a large diame­ter (either anatomically or due to progressive dilatation after CTO), the distal end of this self-expanding stent will open to a smaller extent, and stent malapposition will occur at the lateral wall of the branch, especially the LCX because of its extreme take-off angle. A similar phenome­non may occur when the SB take-off angle becomes pro­gressively larger year after year.